ArticleOPEN ACCESS

Serum TARC: a biomarker for early detection or exclusion of relapse in classic Hodgkin lymphoma

Blood Advances
DOI: 10.1182/bloodadvances.2025015837
3Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Teesink, S. A., Visser, L., Nijland, M., Keijzer, K., Niezink, A. G. H., Kroesen, B. J., … Plattel, W. J. (2025, September 23). Serum TARC: a biomarker for early detection or exclusion of relapse in classic Hodgkin lymphoma. Blood Advances. American Society of Hematology. https://doi.org/10.1182/bloodadvances.2025015837

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free